European Biotech Acquisition Corp. (EBAC)
European Biotech Acquisition Corp. operates in the Shell Companies industry of the Financial Services sector, headquartered in Amsterdam, NL. The stock last traded at $11.19, down 4.44% on the session, giving a market capitalisation of $183.5M. On trailing twelve-month figures it carries a trailing P/E of 41.44, a net margin of 0.0%. Its beta of 0.00 implies it has historically moved less than the broad market.
European Biotech Acquisition Corp. (EBAC) is presently not engaged in substantial business operations. Instead, its core purpose is to facilitate a business combination, potentially through a merger, share exchange, asset acquisition, share purchase, or reorganization, with one or more other companies or organizations. The firm was established in 2021 and its headquarters are located in Amsterdam, the Netherlands.
European Biotech Acquisition Corp. is most often compared with the following Financial Services names: